Aardvark Therapeutics AARD
NASDAQ AARD
$6.82 +0.93 (+15.79%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Change in Acquisitions & Divestments (2025 - 2026)

Aardvark Therapeutics (AARD) posted Change in Acquisitions & Divestments of $34.2 million for Q1 2026, up 17.09% sequentially from $29.2 million in Q4 2025, and up 184.78% YoY from $12.0 million in Q1 2025.

Aardvark Therapeutics (AARD) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

Aardvark Therapeutics has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $34.2 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 184.78% year-over-year to $34.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.2 million (up 750.17% YoY) and the FY2025 annual result came in at $80.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments advanced to $34.2 million in Q1 2026 per AARD's latest filing, from $29.2 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $34.2 million in Q1 2026 and troughed at $9.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Aardvark Therapeutics 147.46 Mn 73.54 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 28.75 Mn
Jun 30, 2026 28.75 Mn
Mar 31, 2026 34.25 Mn
Mar 31, 2026 34.25 Mn
Dec 31, 2025 29.25 Mn
Dec 31, 2025 29.25 Mn
Sep 30, 2025 29.25 Mn
Sep 30, 2025 29.25 Mn
Jun 30, 2025 9.50 Mn
Jun 30, 2025 9.50 Mn
Mar 31, 2025 12.03 Mn
Mar 31, 2025 12.03 Mn